From CVID to PIRD: Genetic Testing Leading to Signal Transducer and Activator of Transcription 3 Gain-of-Function Diagnosis and Directed Therapy.

Saved in:
Bibliographic Details
Title: From CVID to PIRD: Genetic Testing Leading to Signal Transducer and Activator of Transcription 3 Gain-of-Function Diagnosis and Directed Therapy.
Authors: Lang A; Department of Medicine, University of California, San Francisco Medical Center, San Francisco, Calif., Agharahimi A; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., Vogel TP; Division of Rheumatology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas., Weixiong Z; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis., Cooper MA; Division of Rheumatology/Immunology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Mo., Freeman AF; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., Seroogy CM; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic address: cmseroogy@wisc.edu.
Source: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2026 Jul; Vol. 14 (7), pp. 1506-1514. Date of Electronic Publication: 2026 Apr 16.
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-2201
DOI:10.1016/j.jaip.2026.03.041